Robert Goodenow

Robert Goodenow

Plus aucun poste en cours
76 ans
Health Technology
Consumer Services
Miscellaneous

Profil

Robert S.
Goodenow
is currently the Chief Executive Officer at Alanis Therapeutics, Inc. He previously worked as a Principal at Baxter International, Inc., Head-Oncology Business Development at Aventis, Inc., Secretary & Chief Business Officer at Syndax Pharmaceuticals, Inc., and Chief Business Officer at HUYA Bioscience International LLC.
From 2002 to 2007, he served as the Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. Dr. Goodenow holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.

Postes actifs de Robert Goodenow

SociétésPosteDébut

Anciens postes connus de Robert Goodenow

SociétésPosteFin
INOVIO PHARMACEUTICALS, INC. Corporate Officer/Principal 16/03/2007
President -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
Corporate Officer/Principal -
SYNDAX PHARMACEUTICALS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Robert Goodenow

Formation de Robert Goodenow

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

10

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Goodenow
🔇